Breath of hope: inhaled blood thinner tested to save ventilated COVID patients
NCT ID NCT04545541
Summary
This international study tested whether inhaling a mist containing heparin, a common blood thinner, could help COVID-19 patients who need breathing machines. Researchers wanted to see if this treatment could help patients get off ventilators faster and improve survival. The trial involved critically ill adults in intensive care units across multiple countries who were receiving mechanical ventilation for severe COVID-19 pneumonia.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Frederick Health Hospital
Frederick, Maryland, 21701, United States
Conditions
Explore the condition pages connected to this study.